Kytopure Overview

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

Kytopure General Information

Description

Developer of drug delivery and medical products based in Dartmouth, Canada. The company develops and markets a series of clinical therapies and products based on its N O-carboxymethyl chitosan (NOCC) derived technology and its sulfated derivative s-NOCC, enabling healthcare providers to have access to novel therapies and devices to treat patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Delivery
Other Industries
Other Devices and Supplies
Corporate Office
  • 1 Research Drive
  • Dartmouth, Nova Scotia B2Y 4M9
  • Canada
+1 (902) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kytopure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Dec-2022 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Kytopure’s complete valuation and funding history, request access »

Kytopure FAQs

  • Where is Kytopure headquartered?

    Kytopure is headquartered in Dartmouth, Canada.

  • What industry is Kytopure in?

    Kytopure’s primary industry is Drug Delivery.

  • Is Kytopure a private or public company?

    Kytopure is a Private company.

  • What is Kytopure’s current revenue?

    The current revenue for Kytopure is 00000.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »